High-quality, active, and effective antibody is a multi-billion-dollar industry. Merely having hybridoma cells is not enough due to potential risks such as storage accidents, genetic drift, or contamination. Therefore, performing sequence analysis on an antibody ensures that the antibody can be recombinantly produced at any time. Additionally, if you have obtained an effective antibody and wish to protect its intellectual property or expand its production, obtaining accurate antibody sequence is essen......
Quick Search
Products 
